MedTrace Logo

Tele-assessment of the Performance Tests in Patients With Knee Osteoarthritis

NCT06711445 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-12-02

No results posted yet for this study

Summary

The COVID-19 pandemic widely affected delivery mode of healthcare services. While fewer number of patients were allowed to attend face-to-face rehabilitation sessions, some services were totally unavailable due to the safety measures. The COVID-19 crisis highlighted the value and accelerated the improvement of "tele-assessment and tele-rehabilitation" applications. Consequently, reliable remote assessment approaches were required to evaluate the effectiveness of the remote programs. While tests such as TUG, SLS, and 30CST are valid and reliable for clinical use in patients with knee OA, their psychometric properties are yet to be investigated when used as tele-assessment tests. Therefore, this study aimed to examine the intra- and inter-rater reliability of the TUG, SLS, and 30CST as remote tests in patients with knee OA.

Conditions

  • Telerehabilitation
  • Tele-assessment
  • Knee Arthritis Osteoarthritis
  • Performance Measures

Interventions

OTHER

Tele-assessment

The participants were evaluated in two settings on different days (24-48 h apart): (i) in clinical settings (face-to-face) and (ii) at home via 'WhatsApp' phone application (both asynchronized and synchronized tele-assessment). The evaluations steps were as follows: 1. Face-to-face/ Clinic assessment: Rater 1 completed all clinical assessments. 2. Synchronized tele-assessment: Rater 1 repeated the same evaluations via video calls to the patients (these were recorded to be used in step 3). 3. Asynchronized tele-assessment: Rater 2 evaluated the recordings of the remote evaluations (made in step 2). 4. Retest of synchronized tele-assessment: Rater 1 evaluated patients via video calls (these were recorded to be used in step 5). 5. Retest of asynchronized tele-assessment: Rater 2 evaluated the recordings of the remote evaluations (made in step 4).

Sponsors & Collaborators

  • Selcuk University

    lead OTHER

Principal Investigators

  • Gulsah Ozsoy, PhD · Selcuk University

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-15
Primary Completion
2021-11-10
Completion
2021-11-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06711445 on ClinicalTrials.gov